Uranium From Russia; Determination, 44842 [2017-20502]
Download as PDF
44842
Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices
publishing the notice in the Federal
Register on March 7, 2017 (82 FR
12843). The hearing was held in
Washington, DC, on July 25, 2017, and
all persons who requested the
opportunity were permitted to appear in
person or by counsel.
The Commission made these
determinations pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determinations
in these reviews on September 20, 2017.
The views of the Commission are
contained in USITC Publication 4725
(September 2017), entitled Stainless
Steel Sheet and Strip from Japan, Korea,
and Taiwan: Investigation Nos. 701–
TA–382 and 731–TA–800, 801, and 803
(Third Review).
By order of the Commission.
Issued: September 20, 2017.
Lisa R. Barton,
Secretary to the Commission.
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–539–C (Fourth
Review)]
Uranium From Russia; Determination
On the basis of the record 1 developed
in the subject five-year review, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that termination of the
suspended investigation covering
uranium from Russia would be likely to
lead to continuation or recurrence of
material injury to an industry in the
United States within a reasonably
foreseeable time.
Background
BILLING CODE 7020–02–P
By order of the Commission.
Issued: September 20, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–20502 Filed 9–25–17; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
The Commission, pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)),
instituted this review on February 1,
2017 (82 FR 8951) and determined on
May 8, 2017 that it would conduct an
expedited review (82 FR 27287, June 14,
2017).
The Commission made this
determination pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determination in
this review on September 20, 2017. The
views of the Commission are contained
in USITC Publication 4727 (September
[FR Doc. 2017–20501 Filed 9–25–17; 8:45 am]
2017), entitled Uranium from Russia:
Investigation No. 731–TA–539–C
(Fourth Review).
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
Administration as bulk manufacturers of
various classes of controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as manufacturers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
for these notices.
SUMMARY:
Company
FR docket
Insys Manufacturing, LLC ..................................................................................................................................
Eli-Elsohly Laboratories .....................................................................................................................................
Patheon Pharmaceuticals, Inc. ..........................................................................................................................
National Center for Natural Products ................................................................................................................
Research NIDA MPROJECT
Chemtos LLC .....................................................................................................................................................
Chemtos LLC .....................................................................................................................................................
Johnson Matthey Pharmaceutical .....................................................................................................................
Materials, Inc.
American Radiolabeled Chemicals ....................................................................................................................
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823(a) and
determined that the registration of these
registrants to manufacture the
applicable basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed persons.
Dated: September 20, 2017.
Demetra Ashley,
Acting Assistant Administrator.
FR
FR
FR
FR
18:28 Sep 25, 2017
Jkt 241001
PO 00000
Frm 00084
Fmt 4703
19,
19,
19,
19,
2017.
2017.
2017.
2017.
82 FR 23070
May 19, 2017.
DEPARTMENT OF LABOR
Employment and Training
Administration
Updated Methodology for Selecting a
Job Corps Center for Closure and
Center Proposed for Closure:
Comments Requested
Office of Job Corps,
Employment and Training
Administration (ETA), Labor.
ACTION:
Sfmt 4703
May
May
May
May
May 19, 2017.
June 1, 2017.
May 19, 2017.
Notice.
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
VerDate Sep<11>2014
23066
23067
23067
23068
82 FR 23068
82 FR 25335
82 FR 23069
AGENCY:
[FR Doc. 2017–20479 Filed 9–25–17; 8:45 am]
BILLING CODE 4410–09–P
82
82
82
82
Published
E:\FR\FM\26SEN1.SGM
26SEN1
Agencies
[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Page 44842]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20502]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 731-TA-539-C (Fourth Review)]
Uranium From Russia; Determination
On the basis of the record \1\ developed in the subject five-year
review, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that termination of the suspended investigation covering
uranium from Russia would be likely to lead to continuation or
recurrence of material injury to an industry in the United States
within a reasonably foreseeable time.
---------------------------------------------------------------------------
\1\ The record is defined in sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------
Background
The Commission, pursuant to section 751(c) of the Act (19 U.S.C.
1675(c)), instituted this review on February 1, 2017 (82 FR 8951) and
determined on May 8, 2017 that it would conduct an expedited review (82
FR 27287, June 14, 2017).
The Commission made this determination pursuant to section 751(c)
of the Act (19 U.S.C. 1675(c)). It completed and filed its
determination in this review on September 20, 2017. The views of the
Commission are contained in USITC Publication 4727 (September 2017),
entitled Uranium from Russia: Investigation No. 731-TA-539-C (Fourth
Review).
By order of the Commission.
Issued: September 20, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017-20502 Filed 9-25-17; 8:45 am]
BILLING CODE 7020-02-P